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abstract
 
Receptor-mediated modulation of KCNQ channels regulates neuronal excitability. This study con-
cerns the kinetics and mechanism of M
 
1
 
 muscarinic receptor–mediated regulation of the cloned neuronal M
channel, KCNQ2/KCNQ3 (Kv7.2/Kv7.3). Receptors, channels, various mutated G-protein subunits, and an opti-
cal probe for phosphatidylinositol 4,5-bisphosphate (PIP
 
2
 
) were coexpressed by transfection in tsA-201 cells, and
the cells were studied by whole-cell patch clamp and by confocal microscopy. Constitutively active forms of G
 
 
 
q
 
and G
 
 
 
11
 
, but not G
 
 
 
13
 
, caused a loss of the plasma membrane PIP
 
2
 
 and a total tonic inhibition of the KCNQ cur-
rent. There were no further changes upon addition of the muscarinic agonist oxotremorine-M (oxo-M). Expres-
sion of the regulator of G-protein signaling, RGS2, blocked PIP
 
2
 
 hydrolysis and current suppression by muscarinic
stimulation, conﬁrming that the G
 
q
 
 family of G-proteins is necessary. Dialysis with the competitive inhibitor GD-
P
 
 
 
S (1 mM) lengthened the time constant of inhibition sixfold, decreased the suppression of current, and de-
creased agonist sensitivity. Removal of intracellular Mg
 
2
 
 
 
 slowed both the development and the recovery from
muscarinic suppression. When combined with GDP
 
 
 
S, low intracellular Mg
 
2
 
 
 
 nearly eliminated muscarinic inhi-
bition. With nonhydrolyzable GTP analogs, current suppression developed spontaneously and muscarinic inhibi-
tion was enhanced. Such spontaneous suppression was antagonized by GDP
 
 
 
S or GTP or by expression of RGS2.
These observations were successfully described by a kinetic model representing biochemical steps of the signaling
cascade using published rate constants where available. The model supports the following sequence of events for
this G
 
q
 
-coupled signaling: A classical G-protein cycle, including competition for nucleotide-free G-protein by all
nucleotide forms and an activation step requiring Mg
 
2
 
 
 
, followed by G-protein–stimulated phospholipase C and
hydrolysis of PIP
 
2
 
, and ﬁnally PIP
 
2
 
 dissociation from binding sites for inositol lipid on the channels so that KCNQ
current was suppressed. Further experiments will be needed to reﬁne some untested assumptions.
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1
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INTRODUCTION
 
This paper concerns the kinetics of steps in G-protein
signaling to ion channels. The ﬁrst biochemical experi-
ments on the G-proteins G
 
s
 
, G
 
o
 
, G
 
i
 
, and transducin
identiﬁed a cycle of conformational changes that acti-
vates and deactivates G-proteins (Schramm and Sel-
inger, 1984; Birnbaumer et al., 1985; Stryer, 1986; Gil-
man, 1987; Ross, 1995). These test-tube studies used
puriﬁed protein components to measure rates of action
of GTP and GDP analogs, AlF
 
4
 
 
 
, and Mg
 
2
 
 
 
 on nucle-
otide binding, tryptophan ﬂuorescence, and pro-
teolytic susceptibility of the G-protein 
 
 
 
-subunit. They
identiﬁed steps of guanine nucleotide exchange and
guanine nucleotide hydrolysis. Similar kinetic steps
were subsequently recognized in electrophysiological
work on G
 
o
 
-, G
 
i
 
-, and transducin-dependent pathways
of ion channel gating (Sather and Detwiler, 1987; Breit-
wieser and Szabo, 1988; Pfafﬁnger, 1988). Using both
G-protein–activated inward rectiﬁer K
 
 
 
 channels in
heart and cyclic-nucleotide–gated channels in photore-
ceptors, such early work revealed the physiological ki-
netics of G-protein signaling in intact cells. In the case
of photoreceptors, kinetic models could then be for-
mulated to describe the kinetics of phototransduction
(for review see Arshavsky et al., 2002).
Our goal is to carry out a similar biophysical analysis
on a signaling pathway that uses G-proteins of the G
 
q
 
family. Biochemical experiments with puriﬁed G
 
q
 
 and
its relatives have identiﬁed 
 
 
 
-subunits of the G
 
q
 
 family
as the activators of phospholipase C-
 
 
 
s (PLC-
 
 
 
), the en-
zymes that cleave the membrane phospholipid phos-
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S, guanosine-5
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phatidylinositol 4,5-bisphosphate (PIP
 
2
 
) into diacylglyc-
erol and inositol trisphosphate (IP
 
3
 
) (Sternweis and
Smrcka, 1992; Singer et al., 1997). During activation in
vitro, G
 
q
 
 steps through a cycle of nucleotide exchange
and nucleotide hydrolysis like that of other G-proteins.
The kinetics of these steps have been studied with puri-
ﬁed components in lipid vesicles (Mukhopadhyay and
Ross, 1999); however, less is known about the physio-
logical kinetics in cells (see e.g., Pfafﬁnger, 1988; Lo-
pez, 1992). Here we have monitored downstream ac-
tions of PLC in intact cells as measures of G
 
q
 
 activation
while perturbing the system with GTP and GDP ana-
logs, AlF
 
4
 
 
 
, and Mg
 
2
 
 
 
. As an indicator of PLC activity,
we use principally the modulation of an ion channel,
but we also use the translocation of a ﬂuorescent re-
porter protein that is a probe for both a substrate and a
product of PLC. With electrophysiology and confocal
imaging, we have been able to follow the kinetics of G
 
q
 
signaling, from which we have begun to formulate a
preliminary kinetic model of its time course.
Our main PLC indicator is the voltage-dependent
M-current, which can be suppressed by activating M
 
1
 
muscarinic receptors or other receptors linked to G
 
q
 
(Brown and Yu, 2000). A role for G-proteins in M-cur-
rent modulation was recognized early by an irreversible
inhibition of the current when compounds known
to activate G-proteins, such as guanosine-5
 
 
 
-
 
O
 
-(3-thio-
triphosphate) (GTP
 
 
 
S), guanylyl-imidodiphosphate
(GppNHp), or AlF
 
4
 
 
 
, were applied intracellularly with
or without muscarinic agonists (Pfafﬁnger, 1988;
Brown et al., 1989). Evidence has accumulated that the
G-protein involved belongs to the G
 
q/11
 
 family (Pfafﬁn-
ger, 1988; Brown et al., 1989; Caulﬁeld et al., 1994;
Jones et al., 1995; Haley et al., 1998; Shapiro et al.,
2000). It is likely that different G-protein subtypes of
the G
 
q/11
 
 family participate in the transmitter modula-
tion of M-current depending on the cell, receptor sub-
type, and species (Simmons and Mather, 1991; Haley et
al., 2000).
The primary signal for suppression and recovery of
M-current is the G-protein–mediated hydrolysis and de-
pletion of PIP
 
2
 
 in the plasma membrane via activation
of PLC, followed by resynthesis of PIP
 
2
 
. Muscarinic in-
hibition of the M-current is blocked by an inhibitor of
PLC, recovery from inhibition requires cytosolic hydro-
lyzable ATP, and recovery is blocked by inhibitors
of phosphatidylinositol (PI) 4-kinase (Suh and Hille,
2002). The M-current can be depressed by depleting
PIP
 
2
 
 with antibodies or with polycations, and it can be
reactivated by perfusion of PIP
 
2
 
 after suppression by
rundown or exposure to agonists of G
 
q
 
-coupled recep-
tors (Zhang et al., 2003).
The other indicator of PLC activity that we use here
is a ﬂuorescent probe that binds to PIP
 
2
 
 in the mem-
brane and to IP
 
3
 
 in the cytoplasm. This protein con-
struct (PH-EGFP), a fusion protein of the PH domain
of PLC-
 
 
 
1 with enhanced green ﬂuorescent protein,
can be expressed in cell lines and observed by confocal
microscopy in living cells (Stauffer et al., 1998; Varnai
and Balla, 1998). In resting cells, with PIP
 
2
 
 in the
plasma membrane and no cytoplasmic IP
 
3
 
, the PH-
EGFP protein binds to the inner leaﬂet of the plasma
membrane, with little elsewhere in the cell. After PLC
has been activated, the probe migrates into the cyto-
plasm both because of the loss of membrane PIP
 
2
 
 and
because of the generation of cytoplasmic IP
 
3
 
 when PLC
is active (Stauffer et al., 1998; Hirose et al., 1999; Xu et
al., 2003; unpublished data).
 
MATERIALS AND METHODS
 
Cells for Electrophysiology
 
We express the M-current from its KCNQ2/KCNQ3 (Kv7.2/
Kv7.3) channel subunits in a cell line together with M
 
1
 
 receptors.
Plasmids encoding the channel subunits, KCNQ2 (EMBL/Gen-
Bank/DDBJ accession no. AF110020) and KCNQ3 (EMBL/Gen-
Bank/DDBJ accession no. AF091247), provided by David McKin-
non (State University of New York, Stony Brook, NY), were sub-
cloned into the pcDNA3 expression plasmid (Invitrogen). A
plasmid containing mouse M
 
1
 
 muscarinic receptor was provided
by Neil Nathanson (University of Washington, Seattle, WA). Plas-
mids with cloned human RGS2 and constitutively active forms of
human G
 
 
 
q
 
 (Q209L), human G
 
 
 
11
 
 (Q209L), and human G
 
 
 
13
 
(Q226L) were obtained from the Guthrie Research Institute.
The plasmids encoding KCNQ2 and KCNQ3 subunits, the musca-
rinic M
 
1
 
 receptor, and sometimes the G
 
 
 
-subunits were tran-
siently cotransfected into human tsA-201 cells (tsA; derived from
HEK293 cells) using lipofectamine 2000 (Life Technologies), to-
gether with cDNA-encoding green ﬂuorescent protein (GFP) as a
marker for successfully transfected cells (Shapiro et al., 2000).
The 2-ml transfection medium usually contained 0.1 
 
 
 
g of GFP
cDNA and 1 
 
 
 
g of each of the other cDNAs. The next day, the
cells were plated onto poly-
 
l
 
-lysine–coated coverslip chips, and
ﬂuorescent cells were studied within 2 d in electrophysiological
experiments.
 
Confocal Imaging
 
For the ﬂuorescence measurements of PLC activation, we used a
ﬂuorescent indicator of PIP
 
2
 
 and IP
 
3
 
. The tsA cells were cotrans-
fected with 0.25 
 
 
 
g cDNA for PH
 
PLC-
 
 
 
1
 
-EGFP (PH-EGFP) (gift of
Tobias Meyer, Stanford), 1 
 
 
 
g cDNA for M
 
1
 
 receptors, and 2 
 
 
 
g
cDNA for G
 
 
 
-subunits, if used, then transferred to poly-
 
l
 
-lysine–
coated glass coverslips. 1 or 2 d after transfection, the coverslips
were mounted in a perfusion chamber designed for a Leica TCS
NT inverted confocal microscope. Live cells were imaged using a
63
 
 
 
 water objective at 23
 
 
 
C. Control images were obtained for 1
min before drug application. The agonist oxo-M (10 
 
 
 
M) was ap-
plied by gravity feed. Images were processed with Metamorph
(UIC) and Igor Pro (WaveMetrics) to obtain the time course of
the average ﬂuorescence intensity 
 
F
 
 in a cytoplasmic region nor-
malized to the average intensity for 30 s before agonist applica-
tion 
 
F
 
o
 
 (
 
F
 
/
 
F
 
o
 
). In one control experiment, confocal immuno-
cytochemistry was used with ﬁxed cells and anti-KCNQ2 and
-KCNQ3 antibodies to ascertain trafﬁcking of KCNQ channel
subunits, as described (Roche et al., 2002). The cells were ob-
served with a BioRad MRC 600 microscope. 
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Current Recording and Analysis
 
The whole-cell conﬁguration of the patch-clamp technique was
used to voltage-clamp and dialyze cells at 22–25
 
 
 
C. Electrodes
pulled from glass micropipette tubes (VWR Scientiﬁc) had re-
sistances of 1.3–2.5 M
 
 
 
. The whole-cell access resistance was
2–4 M
 
 
 
, and series-resistance error was compensated 
 
 
 
60%. Fast
and slow capacitances were compensated before the applied
test-pulse sequences. When measuring the rates of induction
and recovery from muscarinic inhibition of the current, we ap-
plied test and control solutions rapidly to the 100-
 
 
 
l chamber
(ﬂow rate of 1.5 ml/min) in the vicinity of the recorded cell.
Tests using junction-potential measurements on an open pi-
pette showed that solutions changed with a mean exponential
time constant of 2.4 s, and the change began with a 4–8 s delay
after the command that switches the valve. Thus, there is an
uncertainty of at least 4 s about the time of beginning (but not
the duration) of the agonist exposure. In the ﬁgures, the bar
representing solution change is usually drawn 8 s after the elec-
tronic command occurred. In separate experiments, we esti-
mated the dialysis time for substances included in the whole-
cell pipette by measuring the time course of ﬂuorescence rise
of cells after breakthrough with a pipette containing the ﬂuo-
rescent dye, indo-1. For indo-1 (M.W. 
 
 
 
 645) the diffusion had
an exponential time constant, 
 
 
 
 
 
 
 
120 s. As GDP and GTP ana-
logues have similar molecular weights (460–540), we assumed
that they also exchange into the cell with the same time con-
stant as indo-1.
Currents were monitored by holding the cell at 
 
 
 
20 mV
and applying a 500-ms hyperpolarizing step to 
 
 
 
60 mV every
4 s. For brevity, we will call the current from expressed KCNQ2
and KCNQ3 subunits, KCNQ current. The amplitude of the
KCNQ current usually was deﬁned as the outward current at
the 
 
 
 
20-mV holding potential sensitive to block by 30 
 
 
 
M of
the channel blocker linopirdine. Time courses give the KCNQ
current plotted every 4 s, except where noted. The agonist
oxo-M was always applied at 10 
 
 
 
M unless noted. In most ex-
periments with pipette solutions containing nucleotide ana-
logs, we waited 
 
 
 
300 s after breakthrough before applying
oxo-M to allow time for the dialysis of the analogues into the
cytoplasm.
 
Solutions and Materials
 
The external Ringer’s solution used for current recording and
confocal observations contained (in mM): 160 NaCl, 2.5 KCl, 2
CaCl
 
2
 
, 1 MgCl
 
2
 
, 10 HEPES, and 8 glucose, adjusted to pH 7.4
with NaOH. The standard pipette solution contained (in mM):
175 KCl, 5 MgCl
 
2
 
, 5 HEPES, 0.1 1,2-bis(2-aminophenoxy)ethane
 
N,N,N ,N -tetraacetic acid (BAPTA), 3 Na2ATP, and 0.1 Na3GTP,
titrated to pH 7.4 with KOH (free [Mg2 ] estimated as 2.1
mM, WinMaxc program v2.05, www.stanford.edu/~cpatton/
maxc.html). Variations on this solution are noted in text. The
“Mg2 -free” pipette solution had 1 mM EDTA and no added
Mg2 , corresponding to an estimated free [Mg2 ] of 14 nM, as-
suming a 10  M Mg2  contamination. Pipette solutions said to
contain 100  M AlF4
  had 100  M AlCl3 and 10 mM NaF.
Reagents were obtained as follows: oxotremorine methiodide
(oxo-M) (Research Biochemicals); BAPTA (Molecular Probes);
Dulbecco’s minimum essential medium, fetal bovine serum,
lipofectamine 2000, and penicillin/streptomycin (Life Tech-
nologies); ATP, GTP, guanosine-5 -O-(2-thiodiphosphate)
(GDP S), GppNHp, GTP S, GDP, linopirdine, adenosine-5 -O-
(2-thiodiphosphate) (ADP S), AlCl3, NaF, and atropine (Sigma-
Aldrich).
Data Analysis
Data acquisition and analysis used Pulse/Pulse Fit 8.11 software
in combination with an EPC-9 patch-clamp ampliﬁer (HEKA).
Further data processing and statistical analysis were performed
with Excel (Microsoft) and Igor Pro. Time constants were mea-
sured by exponential ﬁts. All quantitative data are expressed as
mean   SEM and the number of observations is shown in paren-
theses in the histograms. Comparison between two groups was
analyzed using Student’s unpaired t test, and differences were
considered signiﬁcant at a level P   0.05.
Kinetic Modeling
When the experiments were ﬁnished, we sought to represent the
results in a self-consistent kinetic model. Like Xu et al. (2003),
who simulated cellular breakdown of PIP2, we used the Virtual
Cell environment of the National Resource for Cell Analysis and
Modeling, University of Connecticut Health Center (http://
www.nrcam.uchc.edu). In this JAVA-based simulation environ-
ment, components and their reactions are added through a
graphical interface, initial conditions are stated, and the ordi-
nary differential equations are generated and integrated auto-
matically in time by a variable time-step, ﬁfth-order, Runge-Kutta-
Fehlberg routine. The working model with control values of rate
constants and initial conditions is available at that web page for
public use and modiﬁcation.
RESULTS
Gq Couples to PIP2 Hydrolysis and KCNQ Current Inhibition 
in tsA Cells
In our expression system, the exogenously expressed
M1 receptors should couple to endogenous G-proteins
of the Gq family, which would activate endogenous
PLC. We have shown in this system that M1 receptor–
coupled cleavage of PIP2 suppresses the KCNQ K  cur-
rent of exogenously expressed KCNQ2/KCNQ3 chan-
nels and evokes intracellular Ca2  release by an IP3-
dependent pathway (Shapiro et al., 2000; Suh and Hille,
2002). We start by conﬁrming that PLC is coupled to Gq
in these cells.
TsA cells were transfected with the PH-EGFP probe
and M1 receptors, with or without constitutively active,
mutant forms of G-protein   subunits. As expected, the
PH-EGFP probe, which has afﬁnity for membrane PIP2
and cytoplasmic IP3, was concentrated mainly at the
cell surface in unstimulated control cells (circumferen-
tial dark regions in top left panel of Fig. 1 A). Bath ap-
plication of oxo-M led to a rapid translocation (time
constant,      13 s) of the ﬂuorescent probe from the
membrane to the cytoplasm (Fig. 1, A and B). This
translocation was slowly reversed after removal of oxo-M,
recovering on average by 63% in  100 s (Fig. 1 B).
However, when cells were cotransfected with a constitu-
tively active G q subunit (G q*), most of the PH-EGFP
probe was already found in the cytoplasm in resting
cells, and additional incubation with oxo-M did not
change the distribution of ﬂuorescence (Fig. 1, A and
B). Similarly, transfection with a constitutively active666 G-protein Modulation of KCNQ2/KCNQ3 Channels
mutant of another Gq family protein, G 11*, induced a
cytoplasmic distribution of PH-EGFP in resting cells,
and there was no further movement of the probe with
oxo-M. As a control, transfection with constitutively ac-
tive G 13* did not displace PH-EGFP from the mem-
brane or prevent the translocation seen with oxo-M (al-
though the induced translocation was weaker). These
data indicate that exogenous G q* and G 11*, but not
G 13*, can couple to PLC to activate potent PIP2 hydro-
lysis in tsA cells.
Signaling via G-proteins can be depressed by protein
regulators of G-protein signaling, RGS proteins. They
bind to the activated G  subunit and reduce signal-
ing (Hollinger and Hepler, 2002). One RGS protein,
RGS2, is selective for the Gq family and interferes spe-
ciﬁcally with receptor signaling mediated by G q
(Heximer et al., 1997, 1999; Bernstein et al., 2004). We
used it here to further document the involvement of Gq
in muscarinic signaling in tsA cells. As shown in Fig. 1
C, expressing RGS2 had little effect on the resting lo-
calization of PH-EGFP, which was concentrated at the
plasma membrane. However, the RGS2-expressing cells
showed no translocation of PH-EGFP from the mem-
brane during oxo-M treatment (Fig. 1, C and D). Thus,
RGS2 abolishes muscarinic signaling to PLC.
Parallel experiments were done using the KCNQ cur-
rent as an indicator of PLC activation. The cells were
transfected with M1 receptors, KCNQ subunits, and
GFP instead of PH-EGFP as a transfection marker. Fig.
2 A, top left, shows a typical time course of KCNQ cur-
rent as oxo-M is perfused in the bath for 180 s and then
removed. The current is nearly fully suppressed within
12 s (sample points are 4 s apart) in oxo-M and recov-
ers over several hundred seconds after oxo-M is re-
moved. In the control cells, current at  20 mV aver-
aged 923   328 pA (n   10) and was almost completely
inhibited by oxo-M stimulation (Fig. 2, A and B). It re-
covered slowly to 572   256 pA after washout of the ag-
onist. By contrast, in cells expressing constitutively ac-
tive G q*, KCNQ channel activity was essentially absent.
The currents were similar to those seen in tsA cells not
transfected with KCNQ2/KCNQ3 subunits. One expla-
nation for the lack of KCNQ current in these cells
might have been that expression of Gq* prevented
the  trafﬁcking of KCNQ channels to the cell mem-
brane. This possibility was ruled out by control immu-
Figure 1. Constitutively active Gq pro-
teins and RGS2 alter PIP2 hydrolysis in
transfected tsA cells. (A) Fluorescence im-
ages of the PH-EGFP probe in control and
oxo-M–stimulated cells shown in negative
contrast (ﬂuorescence is dark). Cells were
transfected with PH-EGFP with or without
(None) a constitutively active G q (G q*),
G 11 (G 11*), or G 13 (G 13*), and translo-
cation of the probe was monitored by con-
focal microscopy. Images in the right col-
umn were taken 60 s into a 180-s applica-
tion of 10  M Oxo-M to the bath. Black
circles in the top panels represent cytoplas-
mic areas selected for calculation of mean
ﬂuorescence intensity F. The cell nucleus is
made evident by the oxo-M treatment in
the top and bottom panels where there is
transiently more probe in the cytoplasm
than in the nucleus. One can see that the
cytoplasm is a narrow, irregular strip
around a large nucleus. Probe molecules
in the cytoplasm can enter the nucleus
slowly and have already equilibrated in the
middle two panels where constitutive PLC
activation has occurred for hours. (B) Sum-
mary time course of cytoplasmic ﬂuores-
cence ratios (F/Fo) upon addition of oxo-M
(bar and dashed box), as in A. Mean  
SEM for images taken every 5 s. (C) Fluo-
rescence of PH-EGFP in cells transfected
with RGS2. Cells were cotransfected with
PH-EGFP and RGS2, and images were
taken as in A. (D) Summary time course of
cytoplasmic ﬂuorescence ratios.667 Suh et al. 
nocytochemical experiments using antibodies against
KCNQ2 and KCNQ3 proteins. In control cells, immu-
noreactivity for both antibodies was distributed almost
entirely at the cell surface and superpositions showed
complete overlap of KCNQ2 and KCNQ3 (Fig. 2 C). In
Gq-expressing cells the distribution of immunoreactiv-
ity was indistinguishable from that in control cells.
KCNQ currents were also absent with expression of
G 11*, but not with G 13*. However, with G 13* expres-
sion, the action of oxo-M was somewhat slowed and re-
duced, both as measured by PH-EGFP translocation
and by KCNQ current suppression. Likewise, in electro-
physiological experiments, RGS2 severely attenuated
agonist-induced suppression of KCNQ currents (Fig. 2,
D and E). Inhibition by oxo-M was only 16   6% (n  
8). Taken together, these results show that our confocal
and electrophysiological indicators of PLC activity do
reﬂect the activity of G-proteins of the Gq family and
that Gq* is sufﬁciently active to abolish KCNQ current
and PH-EGFP binding to the plasma membrane.
GDP S Slows and Reduces Suppression of KCNQ Current
The canonical G-protein activation cycle starts with
receptor (R)-catalyzed dissociation of GDP from the
G-protein, followed by binding and, eventually, hydro-
lysis of GTP that regenerates the GDP-bound G-protein
(Schramm and Selinger, 1984; Stryer, 1986; Gilman,
1987). This continual recycling can be interrupted if
the transient, nucleotide-free form of the G-protein
(G) binds other nucleotides or nucleotide analogs,
competitively altering the course of activation (simpli-
ﬁed in Scheme I):
Previous studies on sympathetic ganglion neurons
showed that intracellular dialysis of GDP S slows and
decreases receptor-mediated suppression of M-current
(Pfafﬁnger, 1988; Brown et al., 1989), presumably by se-
questering Gq in the inactive Gq·GDP S form. Fig. 3 A
illustrates such changes in our system, comparing tsA
cells dialyzed with 0.1 mM GTP (control), or 1 mM GD-
P S alone, or a mixture of the two. With the standard
0.1 mM GTP in the pipette, steady bath application of
oxo-M suppressed the KCNQ current almost com-
pletely, with a time constant   of 7.6   1.7 s (n   20)
(time constants summarized in Fig. 3 B). With 1 mM
GDP S and no GTP in the pipette, the fast component
of inhibition was slowed approximately sixfold (   
44   6 s; n   7; P   0.001 compared with GTP alone)
and reached only 81   5% after 5 min of oxo-M. In mix-
SCHEME I
Figure 2. Constitutively active Gq proteins and RGS2 alter
KCNQ current. (A) Representative time courses of whole-cell cur-
rent in cells transfected with M1 muscarinic receptor and KCNQ2/
KCNQ3 channel subunits, without (None) or with constitutively
active G  subunits (G*). Oxo-M (10  M) was bath applied for 3
min, and the current measured at  20 mV every 4 s. The inset
shows selected current traces (at times a, b, c) with a dashed line at
zero current. (B) Summary of KCNQ current regulation during
expression of constitutively active G-proteins. The relative current
at the selected time points was measured (symbols) from the indi-
cated number of cells, and the average value is presented as a hori-
zontal bar. (C) Confocal immunocytochemical images of cells
stained with anti-KCNQ antibodies. Images are shown in inverted
contrast with ﬂuorescence being dark. The four panels show anti-
KCNQ2 and -KCNQ3 in control cells and anti-KCNQ2 and
-KCNQ3 in cells cotransfected with Gq*, respectively. (D) Repre-
sentative time course of whole-cell current in RGS2-transfected
cells, showing a reduced response to oxo-M. (E) Summary of
KCNQ current changes in RGS2-transfected cells.668 G-protein Modulation of KCNQ2/KCNQ3 Channels
tures of GTP and GDP S, the slowing was graded with
the fraction of GDP S. On the other hand, addition of
GDP, GppNHp, or ADP S to the pipette without GD-
P S did not reduce either the rate or completeness of
oxo-M–induced channel inhibition (Fig. 3 B). GDP
alone is not expected to support receptor-mediated ac-
tivation of G-proteins, but we suppose that GDP was
phosphorylated to GTP as it entered the cytoplasm in
these experiments (see Suh and Hille, 2002).
Cytoplasmic GDP S slows all aspects of muscarinic
inhibition: onset, turn off, and recovery. In control cells
perfused with 0.1 mM GTP, a 4-s exposure to oxo-M suf-
ﬁces to suppress the KCNQ current by 89   5% (n  
4); the suppression reaches a peak within a few seconds
after oxo-M is washed off; and the current recovers
within a few hundred seconds (Fig. 4 A, top left, open
circles). With GDP S, the same oxo-M treatment gives
only 5–15% inhibition (ﬁlled circles). Muscarinic inhi-
bition increases in a graded manner with longer oxo-M
exposures, and a 40-s exposure is needed for half-maxi-
mal inhibition. Unexpectedly, with the shorter oxo-M
exposures, the development of current suppression
continued long after oxo-M was removed (Fig. 4 A,
top). Even for short exposures, the inhibition kept de-
veloping with a 40-s time constant after oxo-M is re-
moved (Fig. 4 B, bottom). In GDP S-treated cells, it ap-
pears that the G-protein–signaling pathway is activated
only weakly, yet it takes a long time to shut down, and
recovery is weak and slow. We argue later that the de-
layed action can arise because when GDP S dissociates
from the inactive G·GDP S complex, the free G-pro-
tein eventually becomes activated by binding GTP. An
alternative interpretation would be that oxo-M takes
tens of seconds to dissociate from the receptor. This is
unlikely since after 40 s of 10  M oxo-M, the control
trace recovers much faster than the GDP S trace, cross-
ing it. An additional experiment, using only 0.2  M
oxo-M to mimic the smaller net current suppression
seen with GDP S, also showed rapid recovery (Fig.
4 A).
Removing Intracellular Mg2  Retards and Reduces 
Suppression of KCNQ Current
Intracellular Mg2  is necessary for activation of G-pro-
teins. After GDP dissociates from the inactive G-protein
and GTP or a GTP analogue binds, Mg2  promotes a
nearly irreversible conformational change to the active
state and thereby stabilizes the nucleotide binding to
the G-protein (Higashijima et al., 1987a,b). The con-
formational change includes loss of the G  -subunits.
Expanding part of simpliﬁed Scheme I gives Scheme II:
In addition, Mg2  is necessary for the subsequent hy-
drolysis of GTP by the G-protein (Higashijima et al.,
1987a). Note that in Scheme II, the ﬁrst three states of
the G-protein refer to the G    heterotrimer whereas
the ﬁnal active state contains only G .
To look for similar roles for Mg2  in receptor-medi-
ated channel modulation, we dialyzed cells with Mg2 -
free or low-Mg2  pipette solutions and monitored oxo-
M–mediated suppression of KCNQ current. As we have
seen with the standard pipette solution containing 5 mM
total Mg2  (2.1 mM free), oxo-M normally reduces the
current with a 7.6-s time constant. However, eliminating
the Mg2  and including 1 mM EDTA in the pipette
slowed muscarinic inhibition ﬁvefold,     38   5 s (P  
0.001 compared with control, n   13) (Fig. 5 A, left) and
delayed its onset. We argue later that the delay and slow-
SCHEME II
Figure 3. GDP S decreases muscarinic inhibition of KCNQ cur-
rent. (A) Muscarinic modulation of KCNQ current with different
combinations of GTP and GDP S in the pipette solution. Oxo-M
was applied for 5 min and the current is given as mean   SEM val-
ues relative to the preapplication level (n   5–20). (B) Summary
of the time constants of muscarinic inhibition ( ) with different
nucleotide analogues in the pipette solution. *, P   0.01 and **,
P   0.001, compared with 0.1 mM GTP alone.669 Suh et al. 
ing reﬂect the slowness of the last step in Scheme II in
low Mg2  so that it now takes many tens of seconds on av-
erage to activate a G-protein. Fewer active G-protein
complexes are formed per unit time and activation of
PLC is much reduced and delayed. Despite the slowing
of inhibition, the Mg2 -free pipette solution reduced the
ﬁnal extent of inhibition only a little (Fig. 5 B).
Although the molecular mechanisms of action are
different, the effects of Mg2 -free pipette solutions on
the rate and amount of current suppression resembled
those of GDP S. They each delay one of the sequential
steps toward the formation of the ﬁnal active form of
Gq after receptor activation. Interestingly, when the
Mg2 -free condition and GDP S dialysis were com-
Figure 4. GDP S slows and reduces
muscarinic inhibition and recovery of
KCNQ current. (A) KCNQ currents
during applications of 10  M oxo-M
lasting 4, 40, 80, or 180 s. The control
cells (open circles and triangles) have
the standard 0.1 mM GTP pipette solu-
tion. In each panel, the test cells (ﬁlled
circles) have 1 mM GDP S without
GTP in the pipette solution. Each trace
is a different cell. One extra control
trace in the 40-s panel (open triangles)
shows the action of 40 s of 0.2  M oxo-M.
(B) Summaries of the maximum ampli-
tude and time constant of muscarinic
inhibition of current. Oxo-M was ap-
plied for 4, 20, 40, 80, 180, or 300 s to
cells dialyzed with the GDP S-contain-
ing pipette solution.
Figure 5. G-protein–medi-
ated inhibition of current re-
quires intracellular Mg2 . (A)
Inhibition of currents in cells
dialyzed with the 5-mM added
Mg2  pipette solution (open
circles) or with EDTA and no
added Mg2  (ﬁlled circles).
The pipette solutions con-
tained 0.1 mM GTP (left) or 1
mM GDP S (right). (B) Sum-
mary of muscarinic inhibition
of the current after dialysis
with different combinations
of guanine nucleotide ana-
logues and different Mg2 
concentrations. (C) Inhibi-
tion of current by a 20-s oxo-M
stimulation with Mg2 -con-
taining (control) or Mg2 -
free (EDTA) pipette solu-
tion. (D) Summary of time
constants ( ) for musca-
rinic inhibition with different
Mg2  and Ca2  concentra-
tions in the pipette. Oxo-M
was applied for 20 s. The
Mg2  values given are the
added amounts; the free
Mg2  for these solutions is
given in the text.670 G-protein Modulation of KCNQ2/KCNQ3 Channels
bined, oxo-M no longer inhibited KCNQ current (Fig.
5 A, right, and B).
The pipette Mg2  concentration also affected recov-
ery of KCNQ current after short oxo-M exposure (Fig.
5 C). With the standard Mg2 -containing pipette solu-
tion, 20 s of oxo-M treatment suppressed current rap-
idly, and then the current recovered on average to a
level of  70% (n   7) of the preagonist value by 7 min
after washout of the oxo-M (see also Suh and Hille,
2002). However, when the intracellular Mg2  was ab-
sent there was no recovery after washout of oxo-M. In
these experiments, as with GDP S, the onset of inhibi-
tion was delayed, the time course of inhibition (   
46   8 s, n   5) was slowed, and suppression of current
continued to develop long after oxo-M was removed.
We interpret the prolonged action and the lack of re-
covery to a combination of slowed synthesis of PIP2
(Porter et al., 1988) and a slowed GTPase rate (Higash-
ijima et al., 1987b) that prolongs the active state of a
small population of Gq.
In the experiments of Fig. 5, A–C, the free Mg2  in
the pipette was reduced to the low nanomolar range by
adding EDTA. Intermediate reductions could be ob-
tained without EDTA by adding less than the standard
5 mM Mg2  to the solution. Here ATP is the principal
Mg2  buffer. The ﬁrst four solutions in Fig. 5 D have 5,
2, 1, and 0.3 mM added Mg2  and 2,100, 110, 31, and 7
 M free Mg2 . With 110  M free Mg2 , the time course
and magnitude of oxo-M inhibition were nearly normal,
but recovery was already somewhat reduced, whereas,
with 7  M free Mg2 , the inhibition was appreciably
slowed (Fig. 5 D), the magnitude was still nearly nor-
mal, but recovery was nearly absent.
GTP Analogues and AlF4
  Can Activate Gq Spontaneously
G-proteins can be activated slowly without receptor
stimulation by exposure to poorly hydrolyzable GTP
analogues (GTP S, GppNHp) or to AlF4
 . After spon-
taneous dissociation of GDP from the G-protein, the
Figure 6. Agonist-independent inhibition of KCNQ current with G-protein activators. (A) Spontaneous rundown of KCNQ current with
0.1 mM of a nonhydrolyzable GTP analogue, GTP S or GppNHp, or with 0.1 mM AlF4
  in the pipette solution (n   4–7). For the left pan-
els there was no added GTP in the pipette solution. For the right panels there was 0.1 mM GTP. The records start (t   0)  20 s after break-
through. (B) The spontaneous rate of inhibition (initial slope) depends on the ratio of GTP S to GTP. The midpoint of the curve is at a
ratio of 3.6. (C) The spontaneous inhibition rate depends on the concentration of GTP S in the pipette (no added GTP) (n   4–7).671 Suh et al. 
poorly hydrolyzable analogues can react with free G as
in Schemes I and II to capture the G-protein in a stable
active form. On the other hand, AlF4
  reacts directly
with and requires the GDP-bound form to occupy the
site for the   phosphate of GTP (Bigay et al., 1987;
Sondek et al., 1994; Scheme III):
We measured the apparent rates of these reactions by
including 0.1 mM of the GTP analogues or of AlF4
  in
the pipette, without GTP (Fig. 6 A, left). In each case,
the current gradually became completely suppressed
over 100–800 s (note differing time scales) without
any applied agonist. When ﬁtted with single exponen-
tials, spontaneous suppression developed with time con-
stants     63   4 s (n   6) for AlF4
 , 98   7 s (n   6)
for GTP S, and 346   29 s (n   5) for GppNHp. AlF4
 
is the fastest, presumably because it does not require
GDP dissociation (Scheme III). GppNHp is the slowest,
indicating that it reacts more slowly with nucleotide-
free G-protein than GTP S does (or forms a less efﬁ-
cacious active form). Addition of equimolar GTP to-
gether with the GTP analogue to the pipette slows and
attenuates the action of GTP S and GppNHp strongly
(Fig. 6 A, right). The slowing is graded with the ratio of
GTP analogue to GTP (Fig. 6 B), reﬂecting a competi-
tion for nucleotide-free G as expressed in Scheme I.
The action of AlF4
  is not slowed by GTP, conﬁrming
that it does not compete for free G with GTP as in
Scheme III.
The recordings in Fig. 6 began  20 s after the mo-
ment of breakthrough to the whole-cell conﬁguration.
In evaluating them, we need to consider that, during
the ﬁrst minutes, the concentration of the reagents dia-
lyzing from the pipette is gradually increasing in the cy-
toplasm (     120 s for GTP S or GppNHp) and any
endogenous nucleotide is leaving. The slowness of this
diffusional exchange might have delayed the initial re-
action with GTP S or AlF4
 , but it probably did not af-
fect GppNHp, which is intrinsically slower to react.
One check was to repeat the GTP S experiments with
different pipette concentrations of GTP S (Fig. 6 C).
Indeed, the rate of suppression of KCNQ current was
slower for 0.05 mM GTP S and faster for 0.3 and 1 mM
GTP S (Fig. 6 C).
In agreement with Schemes I and II, the spontaneous
suppression of KCNQ current with GTP S is slowed by
including either GDP S-containing or Mg2 -free solu-
tions in the pipette (Fig. 7, A and B). Also in agreement
with predictions, the spontaneous action of AlF4
  is not
slowed by GDP S, although it is slowed by Mg2 -free pi-
pette solutions.
SCHEME III
Nucleotide Analogues Can Diminish or Potentiate
Muscarinic Action
Dissociation of GDP, the ﬁrst step of Schemes I and II,
is catalyzed by activated receptors. The subsequent cap-
ture of the nucleotide-free G-protein by GTP and Mg2 
then increases the fraction of active G-proteins and
hence the physiological output of muscarinic signaling.
By trapping G-proteins in an inactive form, GDP S di-
minishes the receptor-evoked physiological output, and
by forming an active G-protein that is long lasting,
poorly hydrolyzable GTP analogues augment the physi-
ological output. In these ways, nucleotide analogues
should shift the effective dose–response curve for the
oxo-M–induced suppression of KCNQ current. Since
AlF4
  reacts with the GDP form of G-proteins in an
agonist-independent manner, its effect on the dose–
response curve would be different.
Figure 7. Spontaneous current rundown with G-protein activa-
tors is retarded by GDP S and by Mg2 -free pipette solutions. (A)
GDP S blocks agonist-independent channel inhibition by nonhy-
drolyzable GTP analogs. Cells were dialyzed with 1 mM GDP S
plus 0.1 mM GTP S, GppNHp, or AlF4
  (solid lines with error bars
show mean   SEM current; n   5–8). Solid line (lowest line)
shows the current inhibition without GDP S taken from Fig. 7 A,
and the dashed line (highest line) shows the control rundown
when there is 0.1 mM GTP and no GTP analogue or AlF4
  in the
pipette. (B) Removal of intracellular Mg2  (EDTA) slows the
GTP S- and AlF4
 -mediated inhibition. The pipette solution con-
tains 1 mM EDTA and 0.85 mM CaCl2 (lines with error bars are
mean   SEM current; n   5). Bottom line is a representative trace
with 5 mM Mg2  and no EDTA in the pipette.672 G-protein Modulation of KCNQ2/KCNQ3 Channels
To determine agonist dose–response curves, we mea-
sured the ability of various concentrations of oxo-M to
reduce KCNQ current when some of the GTP in the pi-
pette was replaced by other analogs. Consider, for ex-
ample, the three traces for addition of 0.1  M oxo-M in
Fig. 8 A. With GTP in the pipette (top), 0.1  M oxo-M
gives almost 50% reduction of KCNQ current. As ex-
pected, GDP S (middle) decreased the apparent po-
tency of 0.1  M oxo-M in comparison to GTP, whereas
GTP S (bottom) enhanced it greatly. Fig. 8 B shows the
resulting dose–response curves for current inhibition
measured after 3 min in agonist. The EC50 values for
channel inhibition differ by more than two orders of
magnitude: 1.1  M, 103 nM, and 5 nM for GDP S/
GTP, GTP, and GTP S/GTP in the pipette solution. In
each case, the rate of current suppression fell as the
oxo-M concentration was decreased (Fig. 8, C and D).
As in Fig. 3, the initial inhibition rate was greatly slowed
when GDP S was present in the pipette, whereas it
was not changed with GTP S. Additional experiments
showed that the effective dose–response relation also
could be shifted to the left by GppNHp in the pipette
solution (to 76 nM with 0.05 mM GppNHp   0.05
GTP), but not by AlF4
  (102 nM with 0.01 mM AlF4
   
0.1 mM GTP). Overall, these results emphasize the
mechanistic differences of the G-protein reaction with
AlF4
  as compared with the reactions with GTP, GTP S,
or GppNHp. They also reemphasize that the EC50 of
the dose–response curve for physiological outputs is
not a direct measure of receptor occupancy for a G-pro-
tein–coupled receptor. The EC50 is the bottom line of a
long cascade of events and can be altered over orders
of magnitude by agents that may have little effect on re-
ceptor occupancy.
RGS2 Blocks G-protein–coupled Inhibition of KCNQ Current
Expression of RGS2 had profound effects on current
modulation. It prevented the spontaneous suppression
of KCNQ current that normally develops in cells dia-
lyzed with the G-protein activators GTP S or AlF4
 
(Fig. 9 A). In addition, RGS2 potently attenuated the
receptor-mediated suppression of current in cells dia-
lyzed with GTP S, even allowing some recovery (Fig. 9
B). These results indicate that G-proteins of the Gq fam-
ily (the targets of RGS2) are required for the actions of
GTP S and AlF4
  here.
A Working Model for Gq Coupling to KCNQ
Current Inhibition
The putative signaling pathway from M1 muscarinic re-
ceptors to KCNQ current modulation is complex, and
the perturbations we have made could affect several in-
termediate steps. It therefore seemed worthwhile to
test our understanding by an explicit kinetic model in-
corporating all of the postulated steps (Fig. 10). We
wanted to see how far the full range of our observations
could be explained by assembling simple concepts and
kinetic measurements from the literature into a larger
model. We consider this model a ﬁrst approximation to
be reﬁned by future experiments. It has three concep-
tual components: First, the G-protein cycle of Gq and
several side reactions with nucleotide analogues deter-
mine the number of active G-proteins. Then, phospho-
inositide synthesis and breakdown determine PIP2 lev-
els. Finally, the PIP2 level in the membrane governs the
KCNQ current amplitude.
Before examining the model, we summarize what it
can do. It was able to reproduce the following phenom-
ena qualitatively: the time course of inhibition and re-
covery of KCNQ current during oxo-M exposure; spon-
taneous inhibition by GTP analogs; the competition
among nucleotide analogues such that GDP S slows
and diminishes all modes of G-protein activation, ex-
Figure 8. Nucleotide analogues shift the dose–response rela-
tionship for muscarinic inhibition of current. (A) Typical time
courses of muscarinic inhibition of KCNQ current by different
oxo-M concentrations when the pipette contains GTP or GTP plus
a nucleotide analogue as marked. (B) Dose–response relations for
inhibition after 180 s in various concentrations of oxo-M (n  
3–10). (C) The time constant for oxo-M inhibition depends on the
oxo-M concentration and the presence of nucleotide analogues
(n   3–10). (D) The time constant for oxo-M inhibition does not
depend on the GTP S/GTP ratio, which was changed by includ-
ing concentrations of 0/100, 50/50, and 80/20  M, respectively
(n   5–6).673 Suh et al. 
cept AlF4
 , and GTP opposes spontaneous inhibition
by GppNHp; the shift of the dose–response curve by
GDP S and GTP S; and the slowing of all modes of ac-
tivation by Mg2 . Another valuable result was that for-
mulating the model made apparent that the rates of
many essential intermediate steps are not indepen-
dently characterized in the literature. It allowed us to
recognize the gaps in our knowledge.
Formulating the Model and Choice of Rate Constants
The full G-protein cycle is described in the top part of
Fig. 10. The reactions are those in Schemes I, II, and
III, and the rate constants are given in Table I. The lit-
erature provides biochemical measurements that sug-
gest constraints on appropriate values for resting and
stimulated cells. Nevertheless, many individual rate
constants have not been studied, and in several cases
our model constrains them very little. Frequently, the
value chosen is tightly linked to values of other parame-
ters, so that groups of parameters scale together. If one
of them is ﬁxed, then several others fall into place. Bet-
ter values will await additional measurements. We did
not use an automatic ﬁtting program, so the parameter
values are chosen by trial-and-error. We assumed that
similar reactions should have similar rate constants.
The initial dissociation of GDP from G·GDP, step 10,
is catalyzed by receptor (R) occupancy. This is repre-
sented as k10   (OxoSat   0.002), where OxoSat is a sim-
ple saturation function for oxo-M binding to M1 recep-
tors (Koxo    8  M), and 0.002 represents a minute
basal activity of this step in resting cells (possibly con-
stitutive receptor activity). In the absence of agonist,
this spontaneous dissociation of GDP should be fast
enough to allow GTP S to turn off KCNQ current in
Figure 9. RGS2 blocks spontaneous inhibition
by GTP S and AlF4
 , forms of inhibition that are
not governed by GTP hydrolysis. (A) Time course
of current in RGS2-expressing cells dialyzed with
0.1 mM GTP S or AlF4
  (solid lines and error
bars show mean   SEM; n   5–7). The lower,
solid line is the average spontaneous inhibition in
cells not expressing RGS2. (B) Time course of
current inhibition by oxo-M in cells dialyzed with
0.02 mM GTP plus 0.08 mM GTP S in the pipette
solution. Oxo-M was applied twice for 20 s. Top
panel is a cell not transfected with RGS2, and
lower panel is a cell transfected with RGS2.
Figure 10. Kinetic model used to simulate muscarinic modula-
tion of KCNQ current. The model comprises a G-protein cycle
(top), PI metabolism (below), and interaction of PIP2 with KCNQ
channels (bottom). Most steps in the model have conventional ﬁrst-
order or second-order chemical kinetics with rate constants summa-
rized in Table I. Further details are given in the appendix. The rate
constant k40 is deﬁned for the GTPase reaction from right to left,
and all other rate constants (e.g., k10, k20, k30) are for reactions going
from left to right. The reverse reactions, if they are present (see di-
rection of arrowheads) take a negative sign, e.g., k 10, k 20. The
model indicates dissociation of G   from G  during the Mg2  bind-
ing step (step 30) and reassociation of G   in the GTPase step (step
40) in lumped reactions. However, here we have ignored G   as a
species and do not keep track of its concentration. Therefore, none
of the steps is kinetically affected by a “concentration” of G  .674 G-protein Modulation of KCNQ2/KCNQ3 Channels
 100 s. The kinetics of step 10 assumes instantaneous
equilibration of agonist with M1 receptors, ignoring
time dependence of agonist association and dissocia-
tion. Since dissociation of oxo-M from receptors proba-
bly takes  1 s, these events would be too fast to resolve
with our solution exchange system. The quench-ﬂow
biochemical measurements of Mukhopadhyay and Ross
(1999) give rates measured for the GTPase cycle of Gq
with maximal M1 muscarinic stimulation and in the
presence of PLC in a vesicle assay with puriﬁed pro-
teins. In their work, the maximal steady-state rate of
breakdown of GTP during full receptor activation (all
around the cycle) is 0.4 moles GTP s 1 per mole Gq,
and the individual rate constants equivalent to our k10,
k20, and k40 are 0.8 s 1, 5.3   104 M 1 s 1, and 5.3 s 1
(all corrected to 23 C using a Q10 of 2.5). We chose 0.5
s 1, 4.5   105 M 1 s 1, and 1.8 s 1 for the same rate con-
stants. In reconstituted systems, the GTPase activity of
G q is accelerated almost 2,000-fold by interaction with
PLC, i.e., PLC has a potent GTPase acceleratory activity
for Gq (Ross, 1995; Biddlecome et al., 1996; Mukho-
padhyay and Ross, 1999; Cook et al., 2000). In our
model, the GTPase activity of active Gq (step 40) is
given a value closer to that for a complex with PLC
than for the GTP-bound G-protein alone. Step 30, the
reaction of GTP-bound G-protein with Mg2  was made
fast and not rate limiting at 2,100  M free Mg2  (k30  
3   103 M 1 s 1 here and 1.7   104 M 1 s 1 in Higash-
ijima et al., 1987b), but when Mg2  is lowered to the
low micromolar level, that step becomes rate limiting.
The lower part of Fig. 10 shows the second part of the
model involving PIP2 synthesis and turnover. Steps 1
and 2 are PI-4-kinase and PIP-5-kinase. Both steps de-
pend on Mg2  and ATP concentrations, but unlike the
model of Xu et al. (2003), we have not included any ac-
celeration of these lipid kinase steps upon receptor ac-
tivation. PIP2 is recycled back to PIP by PIP2 5-phos-
phatase, step 5. Step 3, the breakdown of PIP2 by the
enzyme PLC, is activated by the active forms of Gq. It is
represented by a rate expression that is simply pro-
portional to the fraction of all active G-proteins
(fGactive) plus a small basal PLC activity (k03   [fGactive  
0.00075]). This description ignores potential diffu-
sional steps for occupied receptors to ﬁnd G-proteins
and for active G-proteins to ﬁnd unoccupied PLC mol-
ecules. Our kinetic assumptions would be literally cor-
rect if the relevant receptors, G-proteins, and PLC mol-
ecules existed and remained in 1:1:1 stoichiometric
complexes throughout, a concept that has been sug-
gested for Gq and PLC (Biddlecome et al., 1996).
Finally, the readout of these events comes from
KCNQ channels. The model assumes that PIP2 binds
reversibly and relatively slowly (seconds) to saturable
sites on KCNQ channels, step 6. Each channel has four-
fold symmetry and probably binds a minimum of four
PIP2 molecules per channel. We chose a power law with
an exponent of 1.8 for the activation of the channel by
the bound PIP2 (see appendix).
The level of PIP2 needed to keep KCNQ channels ac-
tive should not be far below the resting level in the
TABLE I
Model Rate Constants for tsA Cells at 23 C
Step number Mnemonic Forward rate constant Reverse rate constant
01 PI4K 0.0004  M 1 s 1   ATPsat(1000)   (0.2   0.8   Mgsat(20)) NA
02 PIP5K 0.06  M 1 s 1   ATPsat(300)   (0.2   0.8   Mgsat(20)) NA
03 PLC 4.8 s 1   (fGactive   0.00075) NA
04 IP3Pase 0.06 s 1 NA
05 PIP2Pase 0.005 s 1   Mgsat(20) NA
06 PIP2bind 0.00045 d 1 s 1 0.25 s 1
10 GDPdiss 0.5 s 1   (Oxosat(8)   0.002) NA
14 AlF4on 0.0000007  M 1 s 1 0.005 s 1
20 GTPon 0.45  M 1 s 1 0.08 s 1
21 GDP Son 0.28  M 1 s 1   (1   20   Oxosat(8)) 0.1 s 1   (1   20   Oxosat(8))
22 GTP Son 0.006  M 1 s 1 0.005 s 1
23 GppNHpon 0.00048  M 1 s 1 0.005 s 1
30 Mgon 0.003  M 1 s 1 NA
32 Mgon 0.002  M 1 s 1 NA
33 Mgon 0.002  M 1 s 1 NA
34 Mgon 0.002  M 1 s 1 NA
40 GTPase 1.8 s 1   Mgsat(10) NA
The values are given in the micromolar-micrometer-seconds units of Virtual Cell. The functions Oxosat(x), Mgsat(x), and ATPsat(x) are simple saturation
functions of oxo-M, Mg2 , or ATP concentration, with an equilibrium dissociation constant x (in  M). Under our “physiological” conditions Mgsat(20) is
about 0.99, ATPsat(300) is 0.91, and ATPsat(1000) is 0.75. The function fGactive is (G·GTP·Mg2     G·GTP S·Mg2     G·GppNHp·Mg2    
G·GDP·AlF4
 ·Mg2 )/200. d 1, reciprocal density   (molecules per square micrometer) 1.675 Suh et al. 
membrane, since the lag before channels begin to
close during strong receptor activation is short. Thus,
we chose a midpoint for KCNQ activation at 43% of the
resting PIP2 level, which meant that KCNQ channels
are 72% activated at the resting PIP2 level. The resting
PIP2 level should be enough to make several micromo-
lar IP3 if broken down all at once. We used a value of
5,000  m–2 for PIP2 (McLaughlin et al., 2002; Xu et al.,
2003), enough to make 5  M IP3 in the cytoplasm and
nucleus. With a 10  M oxo-M stimulus, most of the
PIP2 should be hydrolyzed by 15 s so that channels
close. After agonist action, enough of the PIP2 should
be restored in  300 s so that channels can reopen.
When PIP2 synthesis is stopped (as with wortmannin),
PIP2 levels should decay over 15 min (Willars et al.,
1998) and KCNQ current should run down in that time
(Suh and Hille, 2002). We chose nearly matching rest-
ing synthesis and breakdown of PIP2 at a rate that
would turn over the entire PIP2 pool with an exponen-
tial time constant of 100 s. About half of this turnover
goes via a futile cycle of PIP2 5-phosphatase back to PIP.
Net replenishment of PIP2 all the way from PI would
have a longer time constant ( 200 s). If every G-pro-
tein could be simultaneously in an active state, the PLC
rate would increase 1,330-fold over the basal level and
the PIP2 pool would be hydrolyzed with a time constant
of 210 ms. With the rate constants chosen and a 0.1 mM
GTP solution in the pipette, only 21% of the G-pro-
teins are simultaneously in the active G·GTP·Mg2  state
during a saturating agonist application, and only 13%
during application of 10  M oxo-M.
The Virtual Cell environment used in running the
model (see materials and methods) uses a speciﬁc
set of self-consistent units. Time is in seconds, and dis-
tance is in micrometers. Concentrations are in micro-
molar for cytoplasmic1 and extracellular molecules and
in molecules per  m2 for membrane molecules. Trans-
lation from cytoplasmic concentrations to membrane
concentrations for mixed reactions is done automati-
cally and requires speciﬁcation of a surface ( m2) to
volume ( m3) ratio. The value we used, 0.6  m 1, is ap-
propriate, e.g., for a round cell of 10  m diameter or a
ﬂattened square box 20   20   5  m (with negligible
organelle volume) and means that releasing 1,000 mol-
ecules  m 2 from the membrane would yield 1.0  M in
the cytoplasm and nucleus.
Results of the Model
We now describe the output of the model, starting with
the control responses to oxo-M application. Fig. 11 A
shows the modeled activation of Gq by a 5-s instanta-
neous step of 10  M oxo-M. At rest, 99.9% of the 200
G-protein molecules per  m2 are in the inactive hetero-
trimeric G·GDP form. After the agonist step, a pool of
active G-proteins develops with a half time of 0.49 s
(reaching 26 active molecules per  m2 in the steady-
state). In this steady-state, 46 GTP molecules  m 2 are
being broken down per second, so 23% of the G-pro-
teins are cycled from G·GDP to G, to G·GTP, to
G·GTP·Mg2 , and back to G·GDP each second and
0.23 moles GTP s 1 is broken down per mole of Gq.
Fig. 11 B shows the consequences for PI turnover and
KCNQ current. In this panel and in the remaining
model ﬁgures, the rise and fall of the agonist (dashed
lines) are assumed to have exponential time constants
of 2.4 s as in our experiments (see materials and
methods and appendix), rather than being instanta-
neous. After agonist is applied, the PIP2 is rapidly de-
pleted (half time   2.7 s) because PLC is active. In ad-
dition, PIP falls a little because PIP regeneration from
1The present model has a single intracellular compartment that we
often refer to as “cytoplasm.” It represents the cytoplasm and the nu-
cleus lumped together.
Figure 11. Early events in receptor activation calculated from
the model with control conditions. (A) G-proteins. A 5-s instanta-
neous application of 10  M oxo-M (dashed lines) rapidly converts
a fraction of the resting G·GDP pool (upper solid line, right axis)
to the other G-protein forms (free G, G·GTP, and G·GTP·Mg2 ,
which is labeled Gactive here) (Gx, solid line, left axis). (B) Down-
stream effects. Time course of decline of inositol lipids PIP and
PIP2 (solid lines) and KCNQ current (solid line with symbols at 4-s
intervals to simulate experimental recordings) during a 10-s appli-
cation of oxo-M (dashed lines). All values are normalized. Oxo-M
rises and falls with a 2.4-s exponential delay (see appendix).676 G-protein Modulation of KCNQ2/KCNQ3 Channels
PIP2 by PIP2 5-phosphatase slows as PIP2 is depleted.
With a resting PIP2 pool of 5,000  m 2 and an invariant
PI 4-kinase producing 18 PIP molecules  m 2 s 1, PIP
and PIP2 recover only slowly when agonist is removed.
The KCNQ current responds to PIP2 changes nonlin-
early and with a delay governed by the kinetics of the
reversible phospholipid binding to the activation sites
on the channel (step 06). Thus, the minimum of
KCNQ current is reached after the minimum of PIP2.
The literature contains no kinetic measurements that
constrain our choice of rate constants for PIP2 binding.
They simply must be fast enough to allow KCNQ cur-
rent inhibition in  8 s.
Fig. 12 shows slowing and blocking of oxo-M action
when a GTP-free, GDP S solution exchanges into the
cytoplasm (compare the experiments in Fig. 4 A). In
these and subsequent simulations with internal re-
agents, the simulation included time-varying intracel-
lular concentrations. Nucleotides are assumed to ex-
change with a 120-s time constant (see materials and
methods and appendix) starting 300 s before the ap-
plication of oxo-M. In this simulation, intracellular
GTP is falling with time as GDP S is rising. The ability
of oxo-M to inhibit KCNQ current declines for both
reasons, and with even longer oxo-M application (see
Fig. 13 A), KCNQ current is already recovering in the
presence of agonist because GTP has been dialyzed
away. The model predicts the strong slowing of inhibi-
tion by GDP S, but it does not predict the near lack of
recovery, for which we suggest a biochemical explana-
tion in discussion.
Fig. 13 simulates Mg2 -free intracellular solution (com-
pare the experiments in Fig. 5, A and C). It is clear that
the model predicts slowing and depression of agonist
action (Fig. 13, A and B) and some continuing develop-
ment of agonist action well after the agonist has been
removed (Fig. 13 B). The low Mg2  also intensiﬁes the
block by GDP S (Fig. 13 A), but not as completely as
was seen experimentally (Fig. 5 A).
Fig. 14 simulates the spontaneous inhibition of
KCNQ currents with dialysis of intracellular GTP ana-
logues or AlF4
  (compare the experiments in Fig. 6).
Unlike in the experiments, spontaneous inhibition has
a sigmoid time course for all three reagents. The ﬁgure
shows that if 0.1 mM GTP is included in the pipette so-
lution, the action of GppNHp is greatly slowed. As in
the experiments, GTP did not affect the action of AlF4
 
in the model (unpublished data).
Fig. 15 gives the predicted dose–response relations
for current suppression by oxo-M (compare experi-
ments in Fig. 8 B). Qualitatively, the predicted effects of
GDP S and GTP S in shifting the dose–response rela-
tion are appropriate, although the effects are not quite
as large as in the experiments. In these simulations,
Figure 12. Model calculations of GDP S antagonizing muscar-
inic suppression of KCNQ current. The control (solid line with
symbols at 4-s intervals) is calculated KCNQ current (left axis) for
a 4-s agonist application. All other solid lines are current with 1000
 M GDP S in the pipette assuming that dialysis started at t  
 210 s. Oxo-M (dashed lines and right axis) is applied for 4,
40, 80, or 180 s starting at t   90 s. Conditions chosen to mimic
Fig. 4 A.
Figure 13. Model calculations of low Mg2  antagonizing musca-
rinic suppression of KCNQ current. (A) Breakthrough is at t  
 260 s and agonist is applied for 300 s starting at t   40 s. The four
pipette solutions are the standard 5-mM added Mg2  solution
(Control) or Mg2 -free pipette solution (EDTA) with 0.1 mM GTP,
or with 1 mM GDP S. Conditions chosen to mimic Fig. 5 A. (B)
Prolongation of G-protein activation in low Mg2 . Agonist is ap-
plied for 20 s starting at t   40 s with control or Mg2 -free (EDTA)
pipette solutions. Conditions chosen to mimic Fig. 5 C.677 Suh et al. 
KCNQ current continued to decline with time through-
out the agonist exposure (unpublished data), rather
than leveling out as in many traces of Fig. 8 B. In addi-
tion, with GTP S, there was considerable spontaneous
inhibition of current developing, so the trace with 1
nM oxo-M showed more total inhibition after 3 min
than in the experiments.
DISCUSSION
As others have shown (Ross, 1995), we ﬁnd that signal-
ing via Gq, can be described by the G-protein cycle of
Fig. 10, the classical scheme developed for Gs, Gi/o, and
transducin. The extent of activation of the signaling
pathway depends on the balance between formation of
nucleotide-free G-protein, followed by binding of GTP
and Mg2 , versus the hydrolysis of GTP to GDP. Ana-
logues act by competing with GTP for the nucleotide-
free form. When cast as a kinetic model, many aspects
of the observations are described qualitatively. Others
have formulated at least partial models of e.g., visual
phototransduction (for review see Arshavsky et al.,
2002), inhibition of adenylyl cyclase activation by  2 re-
ceptors (Thomsen et al., 1988), and even M-current in-
hibition (Simmons and Mather, 1992). Of these, the
phototransduction models rest on the most detailed in-
cell kinetic measurements.
We ﬁrst consider some details of the receptor/G-pro-
tein cycle and then consider PI metabolism and chan-
nel modulation. One of the key goals of making mod-
els is to uncover points of uncertainty. To indicate
such areas, the discussion gives alternative kinetic as-
sumptions that might be evaluated by future deeper
experiments.
Muscarinic Receptors and Gq/11
A large body of evidence shows that G-proteins of the
Gq/11 class (the classical activators of PLC) mediate
muscarinic inhibition of M-current in neurons. This in-
cludes experiments with pertussis toxin, N-ethylmale-
imide, antisense-generating plasmids, antibodies, knock-
out mice, and the knowledge that PLC is activated
and  necessary (Pfafﬁnger, 1988; Brown et al., 1989;
Caulﬁeld et al., 1994; Jones et al., 1995; Haley et al.,
1998, 2000; Shapiro et al., 2000; Suh and Hille, 2002;
Ford et al., 2003; Zhang et al., 2003). For our tsA cells,
we have added mimicry by constitutively active G q*
and full block by Gq-speciﬁc (Heximer et al., 1997,
1999) RGS2. Immunoblotting shows that Gq and G11
are present in superior cervical ganglion neurons (Caul-
ﬁeld et al., 1994).
Our model has neither feedback to receptors that
changes their afﬁnity depending on the presence of
nucleotides and Mg2  (Birnbaumer et al., 1985) nor re-
ceptor desensitization during long agonist applications.
In our experience and in the literature, M1 muscarinic
receptors are not as subject to rapid desensitization as,
for example, adrenergic receptors or bradykinin recep-
tors (Lameh et al., 1992; Wei et al., 1994; Cruzblanca et
al., 1998), and agonist-dependent M1 receptor phos-
phorylation does not always use the typical G-protein–
coupled receptor kinases (Tobin, 1997; Waugh et al.,
1999). In experiments on M1-transfected tsA cells, oxo-M
is able to elicit intracellular Ca2  transients repeatedly
and during long applications (Shapiro et al., 2000; un-
published data); however, new experiments will be
needed to determine the time course and amount of
any desensitization in the cells we use.
Figure 14. Model calculations of spontaneous suppression of
KCNQ with G-protein activators. Breakthrough is assumed to oc-
cur at t    20 s and traces start at t    10 s. The pipette solutions
contain 0.1 mM AlF4
 , GTP S, or GppNHp (lower three traces).
The top trace shows antagonism of 0.1 mM GppNHp by 0.1 mM
GTP. Conditions chosen to mimic Fig. 6.
Figure 15. Calculated oxo-M dose–response relations for inhib-
iting KCNQ current. The pipette solutions contained either GTP
alone or GTP S- or GTP S-containing mixtures to mimic Fig. 8 B.
Time courses of current were calculated from the model during
oxo-M application (not depicted) and the fractional inhibition
measured after 180 s of oxo-M is plotted as symbols.678 G-protein Modulation of KCNQ2/KCNQ3 Channels
Our ﬁnding that RGS2 blocks the suppression of cur-
rent by GTP S and by AlF4
  agrees with biochemical
studies on PLC activation by these agents (Hepler et al.,
1997). The role originally attributed to RGS proteins
was purely to shorten the lifetime of an active G-protein
by accelerating the GTP hydrolysis step. However, the
newer experiments have shown that RGS2 speciﬁcally
forms a trimeric complex with the M1 receptor and acti-
vated Gq, thus blocking access of effectors (Anger et al.,
2004; Bernstein et al., 2004). This additional action ac-
counts for the intensity of the block and the ability to
affect actions of GTPase-resistant nucleotides. We did
not incorporate RGS proteins in our model as we had
no experiments with graded RGS concentrations. How-
ever, a simple approach that would ﬁt the data is to
have them sequester activated Gq as an inactive com-
plex until the bound GTP is broken down.
GDP S
GDP S was developed as an inhibitor of G-protein acti-
vation that competed with GTP and GTP analogues for
the nucleotide-free form of G-proteins (Eckstein et al.,
1979). The probability of capture in the competition
for free G is proportional to the concentrations and the
on-rate constants (k20, k21, k22, k24). Like previous inves-
tigators (Pfafﬁnger, 1988; Brown et al., 1989; Lopez and
Adams, 1989; Simmons and Mather, 1991, 1992), we
found that pipette solutions with a large excess of GD-
P S over GTP slow and diminish agonist-induced inhi-
bition of M-current. The GDP S also prolongs action
after the agonist is removed. In frog sympathetic neu-
rons, the block by GDP S of suppression by agonists
was small and grew with repetitive applications of the
same agonist (Simmons and Mather, 1991, 1992).
Because 1 mM GDP S still allowed an 80% inhibition
of KCNQ current in Fig. 3, one might think that the ef-
fect of the GTP-free GDP S solution is weak. However,
10  M oxo-M is a supra-maximal dose of agonist, and
the signiﬁcant strength of GDP S action should be
judged instead by noting that it slowed the rate of sup-
pression of current sixfold (Fig. 3 B), shifted the oxo-M
dose–response curve10-fold (Fig. 8 B), and reduced the
response to a 4-s oxo-M application by  90% (Fig. 4
A). The slowed onset of inhibition is readily under-
stood as a high probability of capturing free Gq as
G·GDP S instead of as G·GTP. In the model, the G·GD-
P S complex forms reversibly and within a few seconds
it dissociates to free G again; the competition reoccurs,
and once more GDP S is the likely winner. Eventually,
however, GTP and Mg2  will bind, giving a brief stimu-
lation of PLC, and then the GTP is hydrolyzed to re-
store the resting form, G·GDP. In this way, formation of
G ·GTP·Mg2  occurs but is much delayed by cycles of
repeated GDP S binding, so it may occur well after ag-
onist has been removed. Although the model has this
delayed activation, the amount is much less than is seen
in the experiments. To get signiﬁcant delayed activa-
tion by this mechanism requires that the dissociation
rate constant for the G·GDP S complex be signiﬁ-
cantly faster than that for the G·GDP complex in ago-
nist-free conditions. Another explanation is given in
the next paragraph.
The original description of GDP S showed that it
can be phosphorylated slowly by cellular enzymes to
yield GTP S (Eckstein et al., 1979), and subsequent
work suggests that GTP S acts as a very weak persistent
activator (weak “partial agonist”) of G-proteins (Paris
and Pouyssegur, 1990; Blank et al., 1991; Paris and Eck-
stein, 1992). Thus, after some minutes of whole-cell di-
alysis with GDP S, some weak persistent activation
could develop by formation of GTP S. We could mimic
such an effect by including, e.g., 0.0004 mM GTP S in
our calculations for 1 mM GDP S. The simulation (un-
published data) gave better agreement with the near
lack of recovery after oxo-M inhibition in Fig. 4 A, sug-
gesting that some GTP S did form (converting  0.1%
of the GDP S) in our experiments.
The original description of GDP S also showed
for the G-protein Gs that, like GDP dissociation from
G·GDP, GDP S dissociation from G·GDP S is speeded
by receptor occupancy (Eckstein et al., 1979). We in-
cluded a 20-fold speeding of the binding and unbind-
ing reactions for Gq in the model with the afﬁnity for
GDP S not changing; however, this property has not
been explored further for any G-protein, so there was
little information to constrain our assumptions. If such
speeding is correct for GDP S, one wonders if it would
also be found for other nucleotide analogs, at least be-
fore the Mg2 -dependent dissociation of G   subunits.
In bullfrog neurons where GDP S gives an accumu-
lating block under repeated agonist application, the
G·GDP S complex might be stable over many seconds
even in the presence of agonist. Indeed Simmons and
Mather (1992) suggested an irreversible removal of
G-proteins from the available pool. The dissociation in
our model for tsA cells is too rapid to produce such use
dependent depletion.
Agonist-independent Turnover of G Protein
Like previous investigators (Pfafﬁnger, 1988; Brown et
al., 1989; Lopez and Adams, 1989; Lopez, 1992), we
found that pipette solutions with GTP S, GppNHp, or
AlF4
  lead to spontaneous suppression of M-current
over 100–800 s. Our experiments with different con-
centrations of GTP S showed that the analogue con-
centration is rate limiting, and experiments with added
GTP showed that the GTP/analogue ratio is important
(see also Breitwieser and Szabo, 1988; Lopez, 1992).
The action of the two GTP analogues can also be di-
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The nearly exponential time course of spontaneous
current fall observed with GTP analogues (Fig. 6; see
also Lopez, 1992) is mimicked only qualitatively by the
model, which generates a sigmoid time course instead.
To get an exponential fall of current with our model,
one would need a small fraction of G-proteins (and
hence PLC) to be activated initially, with no subsequent
increase in this active fraction. However, in our calcula-
tions, the cytoplasmic concentration of, e.g., GTP S,
starts at zero (at t    20 s) and rises gradually, so that
the irreversible formation of active G-proteins occurs at
an ever-accelerating predicted rate that is initially very
low. For GTP S and GppNHp, the model has a further
lag in onset that comes from the time needed for antag-
onistic GTP to diffuse out of the cytoplasm. In the cal-
culation, we assumed that GTP concentration decays
exponentially to a basal level of 1  M. By the time that
the action of GppNHp develops, the cytoplasmic GTP
is nearly gone. Therefore, the on-rate constant chosen
for GppNHp depends almost directly on this assumed
residual GTP concentration. The higher the residual
GTP, the higher the required GppNHp on-rate con-
stant would have been.
The model could be changed to get an early, weak
G-protein activation and an exponential time course of
spontaneous current decay. One would assume that
GTP S binds much more quickly (1,000 ) than here
and that the resulting complex is much less potent
( 1%) than a GTP complex in stimulating PLC. How-
ever, such a modiﬁcation goes against the accepted
concept that GTP S is a strong activator of G-proteins.
For GTP S and GppNHp, the deduced on-rate con-
stants are several orders of magnitude lower than the
on-rates of GTP and GDP S, and the on-rate for Gpp-
NHp is very much lower than for GTP S. These low val-
ues sufﬁce in Fig. 14 because there remains little GTP
to compete against when the analogues are binding,
and because only a few G-proteins need be perma-
nently activated. A 1% activation of PLC sufﬁces to ex-
plain the observed slow suppression of KCNQ current.
The small amount of activation needed and the ob-
served concentration dependence of the time course
for GTP S action argue against using such time courses
as estimates of the absolute rate of dissociation of GDP
from G·GDP, as might be tempting to do. In our
model, the spontaneous resting rate of GDP dissocia-
tion has a time constant of 1,000 s.
We have emphasized the competition for free G em-
bodied in steps 20, 21, 22, 23, and  10. The agreement
is qualitative as we did not ﬁnd a set of rate constants
that worked optimally across the full range of condi-
tions studied. Thus, the effect of GDP S is a little
strong in Figs. 12 and 13 and a little weak in Fig. 15,
and the antagonistic effect of GTP is ﬁne for the combi-
nation of GppNHp with GTP in Fig. 14 but it is too
weak in an analogous calculation (unpublished data)
for the combination of GTP S with GTP. We think that
some deviations result from not knowing how much
GDP or GTP is present in resting cells and how much
might remain in the cell during dialysis with GDP- and
GTP-free solutions. The model ﬁt could be improved
by assuming that resting GTP is lower and that GTP
changes less during dialysis with GTP-free solution—
for example a resting GTP level of 10  M and a ﬁnal
GTP level of 2  M, instead of 50 and 1  M (see appen-
dix). We lack information on reverse reactions such as
the dissociation of G·nucleotide complexes or the pos-
sible dissociation of the G ·GTP·Mg2  complex by a
mechanism other than the classical GTPase reaction.
Alternatively, there may be errors in the assumed reac-
tion topology or kinetic mechanisms.
Magnesium
Magnesium ions can act at many steps of the G-protein
cycle and PI metabolism. One enzyme it seems not
to stimulate is PLC (Ryu et al., 1987). In agreement
with previous reports about G-protein cascades (Birn-
baumer et al., 1985; Gilman, 1987; Higashijima et al.,
1987a,b), we found that intracellular Mg2  is needed
for onset and termination of G-protein signaling. The
effect was large. The literature shows that Mg2  binds
strongly to the GTP forms but not the GDP forms of Gi,
Go, and Gs (Sprang, 1997), and it locks binding of GTP
to the G  subunit by promoting the conformational
changes of subunit dissociation. Experimentally, with
Mg2  present, there is no measurable dissociation of
GTP S from Go or Gi in 36 min, whereas in the absence
of Mg2 , it dissociates in  2 min from Go and  5 min
from Gi (Higashijima et al., 1987b). The crystal struc-
tures of GTP S-bound G i, G s, and transducin in-
clude a single Mg2  ion coordinated between the   and
  phosphates of GTP and two amino acid hydroxyls of
the G-protein (Sprang, 1997). In our kinetic model,
the on-rate for Mg2  to form the G·GTP·Mg2  complex
is 3,000 M 1 s 1. Hence, with the normal 2.1 mM free
Mg2 , the reaction would occur in only 150 ms, but
with free Mg2  reduced to 1  M, it would take 333 s.
This is the origin of slowed and delayed muscarinic in-
hibition in the absence of Mg2 . During this long wait,
the nucleotide would dissociate and rebind to the
G-protein numerous times, much as was described for
GDP S. At high Mg2  concentrations, the overall reac-
tion might involve binding of Mg2  ﬁrst or direct bind-
ing of Mg2 ·GTP, rather than a two-step reaction (Birn-
baumer et al., 1985).
The absence of Mg2  also slows recovery from musca-
rinic inhibition. Several Mg2 -sensitive steps could be
implicated. One is the GTPase step of the G·GTP·Mg2 
complex (Higashijima et al., 1987b) and the others are
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ter et al., 1988). None is as fully characterized as the
Mg2 -dependent step of G-protein activation. One
problem in much of the literature is that assays are de-
veloped to optimize the amounts of ATP, total Mg2 ,
and other ingredients but do not consider the resulting
free Mg2 . In our reading, it is not deﬁnitively known
whether the GTPase step has Mg2  dependence in ad-
dition to that for initial formation of the G·GTP·Mg2 
substrate. Nevertheless, in our model, steps 30 and
40 both need Mg2 . Step 30 generates the initial
G ·GTP·Mg2  complex, and step 40 hydrolyzes the
GTP. In step 40, the rate of reaction is proportional to a
saturation function of Mg2 , as if the G ·GTP·Mg2 
complex reequilibrates with the ambient Mg2  before
the hydrolysis. As hydrolysis is relatively fast, perhaps
such reequilibration has too little time to occur and the
saturation function should be deleted. Perhaps instead,
the much longer-lived complexes formed in steps
32, 33, or 34 should reequilibrate with the free Mg2 ,
and, e.g., the intrinsic activity of a G ·GTP S complex
might change whether the Mg2  is bound or not. Al-
though the overall model predictions are in the right
direction, there are too many unknowns about Mg2 
dependence today to test such ideas well.
PI Metabolism
We take as a given that muscarinic suppression of
KCNQ current entails signiﬁcant depletion of PIP2 in
the membrane followed by dissociation of PIP2 from
binding sites on the channel. This hypothesis is sup-
ported by many recent electrophysiological and phar-
macological experiments (Suh and Hille, 2002; Ford et
al., 2003; Loussouarn et al., 2003; Zhang et al., 2003).
We also suppose that gradual rundown and incomplete
recovery of KCNQ current after whole-cell recording
starts is in part due to decline and incomplete restora-
tion in PIP2 levels. For example, some of the PI 4-kinase
enzyme is soluble (Wong et al., 1997), and during
whole-cell recording the available pool of this enzyme
might fall as molecules are lost into the recording pi-
pette. However, the recent literature reveals many fac-
tors other than PIP2 that affect the amplitude of KCNQ
currents, so the full explanation of rundown and in-
complete recovery is undoubtedly more complex.
Unfortunately, we cannot adopt ready-made kinetics
of PI turnover from the biochemical literature. The dif-
ﬁculties include that: measurements of total lipids from
cells do not separate contributions of different lipid
pools (both on different membranes and locally on the
plasma membrane itself); measurements often deter-
mine total amounts better than ﬂuxes through pools;
different cell types and compartments have different
lipid kinases and phosphatases; isotopic measurements
of pool sizes may suffer from changes of speciﬁc activ-
ity; and in vitro enzymological experiments with puri-
ﬁed components rarely involve physiological forms of
the lipid substrates in a native membrane.
Finding a range of differing views in the literature,
we tentatively chose a simple textbook kinetic scheme.
Our linear PI-PIP-PIP2 scheme has no regulation of the
lipid-kinase steps other than the requirement for
substrates (lipid and ATP) and Mg2  cofactor, and PI
is considered invariant. Up-regulation of lipid ki-
nases during PLC activation needs to be added when
its mechanism and properties become better known.
Thus, the literature says that Gq-coupled receptor stim-
ulation can potentiate lipid kinases by unknown mech-
anisms (Yorek et al., 1994; Xu et al., 2003), that cAMP-
dependent phosphorylation can turn off PIP 5-kinase
(Park et al., 2001), that several ADP-ribosylation-factor
(ARF)-dependent pathways can regulate PIP-5-kinase
(West et al., 1997; Aikawa and Martin, 2003; Krauss et
al., 2003), and that GTP S can potentiate by activating
Rac-1 and RhoA (Tolias and Carpenter, 2000) or ARF6
(Krauss et al., 2003; West et al., 1997). The RhoA path-
way is also stimulated by G 13 and conceivably under-
lies the changes we saw with constitutively active G13* in
Figs. 1 and 2.
In the model, we ignored PI 5-phosphate and the
possibility of forming PIP2 from it via a PIP 4-kinase,
and we also ignore transfer of PI lipids from other
pools by PI transfer proteins. We included one lipid
phosphatase, PIP2 5-phosphatase, and did not include a
PIP 4-phosphatase. The rates of the 5-phosphatase and
of resting PLC were made about equal, giving some re-
cycling but not a preponderance of futile cycling at
rest. The activation of PLC was linearly proportional to
the sum of active G-protein forms, thus presuming that
GTP, GTP analogs, and AlF4
  give equally active G-pro-
teins. We assume that PLC is completely speciﬁc for
PIP2 and does not hydrolyze PI or PIP. We ignore po-
tential regulation of PLC by G  , cytoplasmic Ca2 , or
PIP2 itself. Each of these assumptions might have to be
revised.
As a single example, we can compare our calculations
to informative measurements made with [3H]inositol
of total membrane inositol lipids in the SH-SY5Y cell
line (Willars et al., 1998). We have general agreement
on the time course of PIP2 decay after muscarinic ago-
nist and after inhibiting PI 4-kinase with wortmannin,
as well as on the time course of PIP2 recovery after re-
moving agonist. However, we do not reproduce two of
their ﬁndings, namely that total PIP falls as fast as PIP2
with agonist and that PIP2 recovers much faster than to-
tal PIP after removal of agonist. In addition their mea-
surements showed that 15% of the resting PIP2 is in an
agonist-insensitive pool.
There is little information about the rate of associa-
tion and dissociation of PIP2 from binding sites on
membrane proteins or about the number of lipid mole-681 Suh et al. 
cules bound per protein. Our assumption that these re-
actions equilibrate in a few seconds adds a short delay
to the response of KCNQ channels. We were not able to
get strong suppression of KCNQ channels without as-
suming that (local) PIP2 itself is strongly depleted. An
extremely cooperative activation of KCNQ channels
could make current turn off suddenly as PIP2 was fall-
ing, but it would make the dose–response curve for
oxo-M too sharp and the time course of suppression by
GTP analogues and AlF4
  even more sigmoid. We as-
sume that the PIP2 binding sites do not bind other
acidic lipids signiﬁcantly.
In summary, many features of the coupling from M1
receptors to KCNQ current suppression are rational-
ized by the classical view of heterotrimeric G-protein cy-
cling and PI turnover. So far as they can be compared,
the properties of isolated systems, of this expression sys-
tem in tsA cells, and of native neurons seem largely
comparable. Much of this could be modeled mathe-
matically using rate constants previously measured
biochemically. By requiring precise speciﬁcation, the
model has highlighted numerous points of uncertainty
that have received less study. Probably the least satisfac-
tory feature of the kinetic measurements is that they in-
volve a single downstream measure (current) that is
mechanistically far removed from the input (agonist).
We will need to design kinetic measurements that re-
veal the time course of many of the intermediates to
constrain numerous assumptions better.
APPENDIX
This appendix gives some additional details of the
kinetic model. The calculations assumed that before
whole-cell dialysis, the tsA cell cytoplasm contained 50
 M GTP, 3 mM ATP, no GDP, and 2.1 mM free Mg2 .
Upon dialysis, GTP, GTP S, GppNHp, and GDP S be-
gan to relax exponentially to their pipette values with a
120-s time constant; AlF4
  relaxed with an 80-s time
constant; and free Mg2  changed immediately. We as-
sumed that dialysis started 300 s before the ﬁrst agonist
application—or 20 s before time zero in Fig. 14, where
agonist was not used. For example, in the control curve
of Fig. 12 (symbols), where the agonist is applied at 90 s
and the pipette contains 100  M GTP, the cytoplasmic
GTP concentration in micromolar is described by the
formula, 50   50   (1   exp( (t   210)/120)), where
breakthrough is taken as time t    210 s. Because cyto-
plasm contains reservoirs of bound Mg2  and the cell
was not in a Mg2 -free bath, we assumed that cellular
free Mg2  never fell below 1  M in experiments with
EDTA rather than to the low nanomolar levels esti-
mated for the pipette solution itself. Similarly, we as-
sumed that cellular GTP fell to 1  M when the pipette
was GTP free. The initial values for PI, PIP, and PIP2
were 200,000, 1,150, and 5,000 molecules  m 2. PI
and GDP were held constant at their initial values
throughout.
Except for Fig. 11 A, the application and removal of
oxo-M was assumed to follow an exponential time
course. Thus, during agonist application, which starts
at t   2 in Fig. 10 B, the rise of oxo-M in micromolar
was described by 10   (1   exp( (t   2)/2.4)). We ar-
bitrarily took the density of Gq on the membrane as 200
 m 2. This value has no effect on the calculations since
activation of PLC was proportional to the fraction of
active G-proteins rather than the number. The fraction
of active G-proteins (fGactive) was taken as (G·GTP·
Mg2     G·GTP S·Mg2     G·GppNHp·Mg2    
G·GDP·AlF4
 ·Mg2 )/200, which assumes that all four
forms have equal intrinsic activity. The density of PIP2
binding sites (on KCNQ channels) was taken as 40
 m 2; the only signiﬁcant property of this number is
that it is several orders of magnitude lower than the
resting PIP2 density, so that channels do not deplete
the PIP2 pool. To allow some cooperativity for activa-
tion of KCNQ current by PIP2, the current varied as a
power law (n   1.8) of the time-varying fractional site
occupancy.
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